Milestone Scientific, Inc. (MLSS): Price and Financial Metrics

Milestone Scientific, Inc. (MLSS): $0.87

0.01 (+1.16%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

MLSS Price/Volume Stats

Current price $0.87 52-week high $1.35
Prev. close $0.86 52-week low $0.41
Day low $0.83 Volume 136,400
Day high $0.91 Avg. volume 84,611
50-day MA $0.88 Dividend yield N/A
200-day MA $0.92 Market Cap 61.81M

MLSS Stock Price Chart Interactive Chart >

MLSS Stock Summary

  • MLSS's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 181.37 -- higher than 85.05% of US-listed equities with positive expected earnings growth.
  • For MLSS, its debt to operating expenses ratio is greater than that reported by merely 8.02% of US equities we're observing.
  • With a price/sales ratio of 5.44, MILESTONE SCIENTIFIC INC has a higher such ratio than 83.25% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to MILESTONE SCIENTIFIC INC are HNST, SNOA, SONM, SPWR, and SIBN.
  • Visit MLSS's SEC page to see the company's official filings. To visit the company's web site, go to www.milestonescientific.com.

MLSS Valuation Summary

  • In comparison to the median Healthcare stock, MLSS's price/sales ratio is 69.44% higher, now standing at 6.1.
  • MLSS's price/sales ratio has moved down 0.5 over the prior 243 months.

Below are key valuation metrics over time for MLSS.

Stock Date P/S P/B P/E EV/EBIT
MLSS 2023-11-03 6.1 7.7 -8.2 -7.6
MLSS 2023-11-02 6.2 7.7 -8.2 -7.7
MLSS 2023-11-01 6.2 7.8 -8.3 -7.7
MLSS 2023-10-31 6.3 7.8 -8.3 -7.8
MLSS 2023-10-30 6.4 8.1 -8.6 -8.0
MLSS 2023-10-27 6.4 8.0 -8.5 -7.9

MLSS Growth Metrics

    Its 5 year cash and equivalents growth rate is now at -73.96%.
  • Its 5 year net income to common stockholders growth rate is now at -50.8%.
  • Its year over year revenue growth rate is now at 53.89%.
Over the past 33 months, MLSS's revenue has gone up $1,036,501.

The table below shows MLSS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 9.411002 -3.221857 -7.85378
2022-06-30 9.303536 -4.135996 -7.925184
2022-03-31 10.08091 -4.557275 -7.747171
2021-12-31 10.30471 -4.017581 -6.818317
2021-09-30 9.670744 -6.376852 -6.776149
2021-06-30 8.808621 -6.556074 -6.223931

MLSS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MLSS has a Quality Grade of C, ranking ahead of 36.73% of graded US stocks.
  • MLSS's asset turnover comes in at 0.423 -- ranking 112th of 186 Medical Equipment stocks.
  • TNDM, TFX, and PEN are the stocks whose asset turnover ratios are most correlated with MLSS.

The table below shows MLSS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.423 0.616 -2.177
2021-03-31 0.315 0.637 -2.538
2020-12-31 0.325 0.666 -3.651
2020-09-30 0.411 0.683 -7.765
2020-06-30 0.616 0.698 30.088
2020-03-31 1.274 0.690 6.927

Milestone Scientific, Inc. (MLSS) Company Bio


Milestone Scientific Inc. operates as a medical technology company. The Company manufactures, markets, and sells computer-controlled local anesthetic delivery systems for plastic surgery, podiatry, dermatology, and orthopedics. Milestone Scientific serves medical sector worldwide.


MLSS Latest News Stream


Event/Time News Detail
Loading, please wait...

MLSS Latest Social Stream


Loading social stream, please wait...

View Full MLSS Social Stream

Latest MLSS News From Around the Web

Below are the latest news stories about MILESTONE SCIENTIFIC INC that investors may wish to consider to help them evaluate MLSS as an investment opportunity.

Milestone Scientific Achieves Revenue of $2.1 Million and Provides Business Update for the Third Quarter of 2023

Reports 45% increase in domestic sales for the third quarter of 2023;new online store providing greater interaction with dentists and improved margins Gross profit margin increases to 73% for the third quarter of 2023, compared to 66% for the same period last year Medical division reports expansion of sales in a prominent hospital system, and pain management clinics Reports progress advancing reimbursement strategy for the CompuFlo® Epidural System ROSELAND, N.J., Nov. 15, 2023 (GLOBE NEWSWIRE)

Yahoo | November 15, 2023

Milestone Scientific Schedules Third Quarter 2023 Financial Results and Business Update Conference Call

ROSELAND, N.J., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Wednesday, November 15, 2023, to discuss the company’s financial results for the third quarter ended September 30, 2023, as well as the company’s corporate progress and other developments. The conference call will be availa

Yahoo | November 10, 2023

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Island Ambulatory Surgery Center in Brooklyn, New York

Represents first sales by the Company into an ambulatory surgery center Follows successful evaluation by Island Ambulatory Surgery Center’s founder and medical director, Dr. Leon Reyfman, reporting 100% success ROSELAND, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo® Epidural disposables into Island Am

Yahoo | November 9, 2023

Milestone Scientific Appoints Pain Management Industry Veteran Dr. Didier Demesmin to its Board of Directors

ROSELAND, N.J., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of Dr. Didier Demesmin, MD, MBA, to the Board of Directors. Dr. Demesmin is an interventional pain medicine physician who is double board-certified in both anesthesiology and pain medicine. He is the founder of University Pain and Spine center, a well-respected interve

Yahoo | September 12, 2023

Milestone Scientific Achieves 77% Year-Over-Year Increase in Revenue to $2.9 Million for the Second Quarter of 2023

Gross profit increases 178% compared to the same period last year New online store providing greater interaction with dentists and improved margins Medical division reports positive reimbursement from first commercial payers ROSELAND, N.J., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the seco

Yahoo | August 15, 2023

Read More 'MLSS' Stories Here

MLSS Price Returns

1-mo -3.33%
3-mo -18.69%
6-mo -16.35%
1-year 40.32%
3-year -50.29%
5-year 64.15%
YTD 81.25%
2022 -76.70%
2021 -2.83%
2020 52.52%
2019 318.67%
2018 -71.86%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!